Related Experiment Video
Updated: Oct 23, 2025

08:46
A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Published on: August 12, 2020
6.6K
Neonatal MIS-C: Managing the Cytokine Storm
Sumita Saha1, Priyankar Pal2, Devdeep Mukherjee3
1Fortis Hospital, Anandapur, Kolkata, India sumitas74@gmail.com.
Pediatrics
|August 26, 2021
Summary
A newborn developed severe multisystem inflammatory syndrome in children (MIS-C) following COVID-19 infection. This rare case highlights refractory myocarditis, gastrointestinal, and renal issues in neonatal MIS-C.
Area of Science:
- Neonatology
- Pediatric Infectious Diseases
- Critical Care Medicine
Background:
- Late-onset sepsis and persistent thrombocytopenia were initially diagnosed in a term infant.
- The infant presented with recurrent fever, diarrhea, and a maculopapular rash, prompting further investigation.
Observation:
- COVID-19 infection was confirmed via RT-PCR in the infant.
- The infant rapidly developed cardiogenic shock, pulmonary edema, anemia, and thrombocytopenia, requiring mechanical ventilation.
Findings:
- Diagnosis of multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19 was made.
- The infant experienced seizures, pulmonary hemorrhage, cardiac arrest, and acute kidney injury, indicating severe systemic involvement.
- Refractory myocarditis, gastrointestinal, and renal manifestations were prominent features of this neonatal MIS-C case.
Implications:
- This case underscores the potential for severe, multi-organ system disease in neonates with COVID-19.
- It highlights the diagnostic challenges and critical care needs in neonatal MIS-C.
- The unique dermatologic manifestations in neonatal COVID-19 warrant further study.
Related Concept Videos
Myocarditis IV: Nursing Management
61
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
61
Acute Respiratory Failure-V
242
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
242
Myocarditis III: Medical Management
33
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
33

